CN111065636A - 稠合杂芳基衍生物、其制备方法及其在医药上的应用 - Google Patents
稠合杂芳基衍生物、其制备方法及其在医药上的应用 Download PDFInfo
- Publication number
- CN111065636A CN111065636A CN201880058416.5A CN201880058416A CN111065636A CN 111065636 A CN111065636 A CN 111065636A CN 201880058416 A CN201880058416 A CN 201880058416A CN 111065636 A CN111065636 A CN 111065636A
- Authority
- CN
- China
- Prior art keywords
- groups
- group
- compound
- alkyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Description
Claims (26)
- PCT国内申请,权利要求书已公开。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710866425 | 2017-09-22 | ||
CN2017108664254 | 2017-09-22 | ||
PCT/CN2018/106983 WO2019057158A1 (zh) | 2017-09-22 | 2018-09-21 | 稠合杂芳基衍生物、其制备方法及其在医药上的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111065636A true CN111065636A (zh) | 2020-04-24 |
CN111065636B CN111065636B (zh) | 2022-08-23 |
Family
ID=65810062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880058416.5A Active CN111065636B (zh) | 2017-09-22 | 2018-09-21 | 稠合杂芳基衍生物、其制备方法及其在医药上的应用 |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN111065636B (zh) |
TW (1) | TW201915000A (zh) |
WO (1) | WO2019057158A1 (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102272134A (zh) * | 2008-12-09 | 2011-12-07 | 吉里德科学公司 | Toll样受体调节剂 |
CN102439011A (zh) * | 2009-02-11 | 2012-05-02 | 加利福尼亚大学校务委员会 | Toll样受体调节剂和疾病的治疗 |
WO2013117615A1 (en) * | 2012-02-08 | 2013-08-15 | Janssen R&D Ireland | Piperidino-pyrimidine derivatives for the treatment of viral infections |
CN107074860A (zh) * | 2014-09-16 | 2017-08-18 | 吉利德科学公司 | 制备toll样受体调节剂的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD20170081A2 (ro) * | 2015-03-04 | 2018-03-31 | Gilead Sciences, Inc. | Compuşi 4,6-diamino-pirido[3,2-D]pirimidină modulatori ai receptorilor de tip Toll |
-
2018
- 2018-09-21 CN CN201880058416.5A patent/CN111065636B/zh active Active
- 2018-09-21 TW TW107133417A patent/TW201915000A/zh unknown
- 2018-09-21 WO PCT/CN2018/106983 patent/WO2019057158A1/zh active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102272134A (zh) * | 2008-12-09 | 2011-12-07 | 吉里德科学公司 | Toll样受体调节剂 |
CN103497192A (zh) * | 2008-12-09 | 2014-01-08 | 吉里德科学公司 | Toll 样受体调节剂 |
CN102439011A (zh) * | 2009-02-11 | 2012-05-02 | 加利福尼亚大学校务委员会 | Toll样受体调节剂和疾病的治疗 |
WO2013117615A1 (en) * | 2012-02-08 | 2013-08-15 | Janssen R&D Ireland | Piperidino-pyrimidine derivatives for the treatment of viral infections |
CN107074860A (zh) * | 2014-09-16 | 2017-08-18 | 吉利德科学公司 | 制备toll样受体调节剂的方法 |
Non-Patent Citations (2)
Title |
---|
EMMANUEL H. DEMONT ET AL.: "Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors", 《J. MED. CHEM》 * |
PAUL BAMBOROUGH ET AL.: "Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors", 《J. MED. CHEM》 * |
Also Published As
Publication number | Publication date |
---|---|
WO2019057158A1 (zh) | 2019-03-28 |
CN111065636B (zh) | 2022-08-23 |
TW201915000A (zh) | 2019-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI760390B (zh) | 吡唑並雜芳基類衍生物、其製備方法及其在醫藥上的應用 | |
CN110177793B (zh) | 杂芳基并吡唑类衍生物、其制备方法及其在医药上的应用 | |
CN108794486B (zh) | 稠环基酮类衍生物、其制备方法及其在医药上的应用 | |
CN108948016B (zh) | 嘌呤酮类衍生物、其制备方法及其在医药上的应用 | |
CN111094289A (zh) | 吡啶并嘧啶类衍生物、其制备方法及其在医药上的应用 | |
CN110317202B (zh) | 氰基吡咯并杂芳基类衍生物、其制备方法及其在医药上的应用 | |
WO2022017365A1 (zh) | 含硫异吲哚啉类衍生物、其制备方法及其在医药上的应用 | |
US11932663B2 (en) | Phosphorus imidazoquinoline amine derivatives, pharmaceutical compositions and therapeutic methods thereof | |
CN111065636B (zh) | 稠合杂芳基衍生物、其制备方法及其在医药上的应用 | |
CA3234693A1 (en) | Novel modulators of ehmt1 and ehmt2 and therapeutic use thereof | |
CN112574212B (zh) | 一种嘧啶并五元氮杂环类衍生物、其制备方法及其在医药上的应用 | |
CN111433201B (zh) | 苯并氮杂䓬衍生物、其制备方法及其在医药上的应用 | |
JP2020504109A (ja) | アザビシクロ置換トリアゾール誘導体、その調製方法、及びその医薬用途 | |
CN109694351B (zh) | 苯并氮杂*衍生物、其制备方法及其在医药上的应用 | |
CN109937205B (zh) | 杂芳基并噻二嗪-2,2-二氧化物类衍生物、其制备方法及其在医药上的应用 | |
CN109956903B (zh) | 苯并氮杂䓬衍生物、其制备方法及其在医药上的应用 | |
WO2023011608A1 (zh) | 含三并环类衍生物调节剂、其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230522 Address after: 222047 No. 7 Kunlun Shan Road, Lianyungang economic and Technological Development Zone, Jiangsu Patentee after: JIANGSU HENGRUI MEDICINE Co.,Ltd. Patentee after: Shandong Shengdi Pharmaceutical Co.,Ltd. Patentee after: SHANGHAI HENGRUI PHARMACEUTICAL Co.,Ltd. Address before: 222047 No. 7 Kunlun Shan Road, Lianyungang economic and Technological Development Zone, Jiangsu Patentee before: JIANGSU HENGRUI MEDICINE Co.,Ltd. Patentee before: SHANGHAI HENGRUI PHARMACEUTICAL Co.,Ltd. |